SMAD4 and neoplasm: In a genetically-engineered Apc+/∆716/Smad4+/− compound knockout mice that develop invasive intestinal adenocarcinomas [87], mouse CCL9 (mCCL9) is secreted from the cancer epithelium, which recruits CCR1+ myeloid cells to promote tumor invasion [38].